Around 40% of relapsing-remitting MS cases present with apparent Th17-cell expansion with a positive correlation between Th17-cell numbers and ENTPD1/CD39+ Treg frequencies during remission but not during relapse. Here, ENTPD1 is linked to relapsing-remitting multiple sclerosis.